Metraipolis › archive › dc_debb36cf65dc

Hypochlorous Acid-Responsive Prodrug Nanoplatform for Synergistic Cancer Immunotherapy — Europe PMC PMID:41583068

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41583068
DOI
10.34133/bmr.0300
License (as archived)
solo-consultazione
Archived
2026-11-06T13:16:05.741Z
SHA-256 of the archived text
87af411196435311e00b6656c1bdcec5105fc99800e16cf9e0ec38d948652639
Stable URL of this page
https://metraipolis.com/documento/dc_debb36cf65dc

How to cite

Hypochlorous Acid-Responsive Prodrug Nanoplatform for Synergistic Cancer Immunotherapy — Europe PMC PMID:41583068 — Europe PMC (en), https://europepmc.org/article/MED/41583068 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_debb36cf65dc (Metraipolis archive dc_debb36cf65dc, sha256 87af411196435311e00b6656c1bdcec5105fc99800e16cf9e0ec38d948652639)
BibTeX
@misc{dcdebb36cf65dc,
  title = {Hypochlorous Acid-Responsive Prodrug Nanoplatform for Synergistic Cancer Immunotherapy — Europe PMC PMID:41583068},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41583068},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_debb36cf65dc; sha256 87af411196435311e00b6656c1bdcec5105fc99800e16cf9e0ec38d948652639},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41583068. Agents can read the archived copy with the MCP tool read_document.